{"id":"W2135038122","doi":"10.1016/s0140-6736(03)14282-1","title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","year":2003,"lang":"en","type":"article","venue":"The Lancet","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1892,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"AstraZeneca","keywords":"Candesartan; Medicine; Heart failure; Ejection fraction; Hazard ratio; Internal medicine; Placebo; ACE inhibitor; Cardiology; Angiotensin II; Angiotensin-converting enzyme; Blood pressure; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}